- Trials with a EudraCT protocol (9)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
9 result(s) found for: convalescent plasma.
Displaying page 1 of 1.
EudraCT Number: 2020-001936-86 | Sponsor Protocol Number: COMET | Start Date*: 2020-10-19 | |||||||||||
Sponsor Name:Hannover Medical School | |||||||||||||
Full Title: A prospective, randomized, open label Phase 2 clinical trial to evaluate superiority of anti-SARS-CoV-2 convalescent plasma versus standard-of-care in hospitalized patients with mild COVID-19 | |||||||||||||
Medical condition: Hospitalized patients with mild SARS-CoV-2 infection (WHO R&D Blueprint Ordinal Scale for Clinical Improvement = 3 or 4) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-002122-82 | Sponsor Protocol Number: UKER-COV2-01 | Start Date*: 2020-06-12 | ||||||||||||||||
Sponsor Name:Universitätsklinikum Erlangen | ||||||||||||||||||
Full Title: Prospective open-label randomized controlled phase 2b clinical study in parallel groups for the assessment of efficacy and safety of immune therapy with COVID-19 convalescent plasma plus standard t... | ||||||||||||||||||
Medical condition: ARDS due to COVID-19 necessitating invasive mechanical ventilation | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001310-38 | Sponsor Protocol Number: CAPSID2020-DRK-BSD | Start Date*: 2020-04-06 | ||||||||||||||||||||||||||
Sponsor Name:DRK-Bluspendedienst Baden-Württemberg - Hessen gGmbH | ||||||||||||||||||||||||||||
Full Title: A randomized, prospective, open label clinical trial on the use of convalescent plasma compared to best supportive care in patients with severe COVID-19 | ||||||||||||||||||||||||||||
Medical condition: Patients with SARS-CoV-2 infection and: 1. age ≥ 18 years and ≤ 75 years 2. SARS-CoV-2 infection confirmed by PCR (BAL, sputum, nasal and/or pharyngeal swap) 3. severe disease ... | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: DE (Ongoing) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-004695-18 | Sponsor Protocol Number: RES-Q-HR | Start Date*: 2020-12-02 | ||||||||||||||||||||||||||
Sponsor Name:Heinrich-Heine-University Düsseldorf | ||||||||||||||||||||||||||||
Full Title: Reconvalescent plasma/Camostat mesylate early in Sars-CoV-2 Q-PCR positive high risk individuals | ||||||||||||||||||||||||||||
Medical condition: The novel coronavirus designated SARS CoV-2, and the disease caused by this virus designated COVID-19. No treatment is available for early disease stages and non-hospitalized patients to date. This... | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: DE (Ongoing) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001367-88 | Sponsor Protocol Number: 25032020 | Start Date*: 2020-04-14 | |||||||||||
Sponsor Name:Department of Infectious diseases | |||||||||||||
Full Title: Efficacy and safety of novel treatment options for adults with COVID-19 pneumonia. A double-blinded, randomized, multi-stage, 6-armed placebo-controlled trial in the framework of an adaptive trial ... | |||||||||||||
Medical condition: COVID-19 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-001411-25 | Sponsor Protocol Number: XPORT-COV-1001 | Start Date*: 2020-05-18 | |||||||||||
Sponsor Name:Karyopharm Therapeutics Inc. | |||||||||||||
Full Title: A Phase 2 Randomized Single-Blind Study to Evaluate the Activity and Safety of Low Dose Oral Selinexor (KPT-330) in Patients with Severe COVID-19 Infection | |||||||||||||
Medical condition: Severe COVID-19 Infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) FR (Completed) AT (Prematurely Ended) GB (GB - no longer in EU/EEA) ES (Temporarily Halted) IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001632-10 | Sponsor Protocol Number: SARS-CoV-2CP-HD-001 | Start Date*: 2020-05-04 | ||||||||||||||||||||||||||||||||||||
Sponsor Name:Ruprecht-Karls-Universität Heidelberg, Medical Faculty, University Hospital Heidelberg - | ||||||||||||||||||||||||||||||||||||||
Full Title: A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 D... | ||||||||||||||||||||||||||||||||||||||
Medical condition: Coronavirus disease 2019 (COVID-19) / SARS-CoV-2 Disease | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||
Trial protocol: DE (Ongoing) | ||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-003343-29 | Sponsor Protocol Number: RG_12-179 | Start Date*: 2013-01-18 | |||||||||||
Sponsor Name:University of Birmingham | |||||||||||||
Full Title: Simvastatin as adjuvant therapy to correct neutrophil dysfunction in older pneumonia patients - a randomised double blind placebo controlled trial | |||||||||||||
Medical condition: Acute episodes of Pneumonia and sepsis in older adults | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-001302-30 | Sponsor Protocol Number: ACOVACT | Start Date*: 2020-04-15 | ||||||||||||||||||||||||||
Sponsor Name:Medical University of Vienna | ||||||||||||||||||||||||||||
Full Title: A multicenter, randomized, active controlled, open label, platform trial on the efficacy and safety of experimental therapeutics for patients with COVID-19 (caused by infection with severe acute re... | ||||||||||||||||||||||||||||
Medical condition: Infection with SARS-COV-2 (=COVID-19) | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: AT (Ongoing) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
